Summit Therapeutics · NASDAQ: SMMT · Biotechnology
Over the past week, Summit Therapeutics (SMMT) racked up about 12 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 21% bullish but is sharply divided: News runs 62% bullish while X sits at just 0%. Wall Street is more constructive, with 10 of 17 analysts rating SMMT a buy.
There is little buzz around SMMT this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 59% buy share sits next to a crowd that ranges from X at 0% to News at 62%. No other tracker puts the two side by side.
17 analysts have weighed in: a Buy consensus: 10 buy calls against 2 sell, with an average 12-month price target of $28.69.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 38 points above the crowd average of 21%, the professionals are more constructive than retail. The split is inside the crowd: News reads 62% bullish while X sits at 0%, a 62-point spread that single-source trackers miss.
Over the 30-day window, Summit Therapeutics (SMMT) buzz held subdued around 26.9 while the price drifted up 7.9% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 5.3M shares. Updated Jul 13, 2026. Over the last 7 trading days, SMMT gained 6.1%. Buzz activity in the recent week averaged 27.4 and was relatively stable, swinging between 24.7 and 30.6. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 11 of the 16 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Buzz, bullish share, the loudest item and the positive / neutral / negative split for every tracked source over the last 7 days.
No Polymarket data for this stock this week.
Query sentiment for SMMT and 1000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live SMMT sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Jul 13, 2026.
Based on aggregated sentiment from Reddit, X and News sources, Summit Therapeutics (SMMT) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 21% bullish across 3 active sources. Those sources contribute 12 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Summit Therapeutics (SMMT) is fairly quiet with 1 mentions across 3 tracked subreddits. The tone is 0% bullish with stable 3-day activity momentum, suggesting steady attention.
Summit Therapeutics (SMMT) sentiment is bearish across all 3 tracked sources. X reads 0% bullish, News reads 62% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
Social sentiment data shows consistently bearish discussion around Summit Therapeutics (SMMT). All 3 tracked sources lean negative, with reddit being the most bearish at 0% bullish. The sell signal carries 93/100 conviction.
News is the dominant discussion channel with 8 mentions (67% of total volume). X contributes 3 mentions and Reddit contributes 1 mentions. Sentiment is bearish across all sources.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. SMMT's sell signal at 93/100 conviction reflects consistently bearish sentiment across multiple platforms. It is a research shortcut, not financial advice.
The SMMT sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
These stocks share a comparable sentiment profile to Summit Therapeutics with similar bullish ratios, signal direction and discussion volume. All 6 peers carry sell signals, pointing to broad bearish pressure rather than an SMMT-specific issue.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key